An investigation into the physiological relevance of the vagal tachycardia in the anaesthetized dog
- 31 January 2006
- journal article
- Published by Wiley in Acta Physiologica
- Vol. 186 (3) , 179-184
- https://doi.org/10.1111/j.1748-1716.2006.01524.x
Abstract
Aim: Our aim was primarily to assess whether or not a vagal tachycardia can be elicited in vivo without administration of atropine, and secondly to evaluate whether the dose of atropine, a muscarinic antagonist, determines the magnitude of the tachycardia.Methods: Experiments were carried out in the presence of atenolol (2 mg kg−1). The vagal tachycardia requires high vagal activity which was induced by noradrenaline infusion (20 μg min−1). Two techniques were then used to elicit a tachycardia, vagal section and atropine administration.Results: The increase in blood pressure caused heart rate to fall to 60 ± 7 beats min−1 (mean ± SEM). When the vagi were sectioned (n = 5) heart rate increased by 9 ± 2 beats min−1 above the intrinsic rate which was 108 beats min−1, this increase was not significant. In contrast atropine given (9–20 μg kg−1) (n = 5) during high vagal activity increased heart rate by 81 ± 22 beats min−1 above the intrinsic rate (P < 0.05). To assess if the dose of atropine affects the magnitude of the vagal tachycardia, the right vagus was stimulated electrically at increasing frequencies (2, 4, 8, 16, 32 Hz) before and after increasing doses of atropine (0.02, 0.05, 1 mg kg−1). This reduced the magnitude of the bradycardia; however, the magnitude of the vagal tachycardia was unaffected.Conclusion: The vagal tachycardia cannot be elicited without atropine suggesting that it does not play a significant physiological role.Keywords
This publication has 13 references indexed in Scilit:
- Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Goteborg, SwedenHeart, 2003
- The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dogNeuropeptides, 2001
- Central Vagotonic Effects of Atropine Modulate Spectral Oscillations of Sympathetic Nerve ActivityCirculation, 1998
- Mechanism of the decline in vagal cardiac acceleration in dogs in neuroleptanaesthesiaJournal of the Autonomic Nervous System, 1995
- Frequency dependence of vasoactive intestinal polypeptide release and vagally induced tachycardia in the canine heartJournal of the Autonomic Nervous System, 1993
- Synergistic hypotensive effect of vasoactive intestinal polypeptide and alpha-blockade with phentolamine. Evidence for vasoactive intestinal peptide alpha-adrenoceptor coupling in the cardiovascular system of newborn dogs.Circulation Research, 1990
- Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heartCell and tissue research, 1984
- Cardioacceleratory effect of muscarinic blocking agents in the dogEuropean Journal of Pharmacology, 1981
- An Approach to the Problems of Acid-Base BalanceClinical Science, 1970
- Mechanisms of tachycardia caused by atropine in conscious dogsAmerican Journal of Physiology-Legacy Content, 1967